The Flow Cytometry Market was valued at $6,216.42 million in 2022 and is estimated to reach $16,577.98 million by 2032, exhibiting a CAGR of 10.3% from 2023 to 2032. Flow cytometry is a powerful technique used to analyze and quantify the characteristics of individual cells or particles in a heterogeneous mixture. It operates on the principle of passing cells through a narrow, focused stream of fluid, allowing them to pass single file through a laser beam. As cells pass through the laser beam, they scatter and emit fluorescent light, which is collected by detectors. Flow cytometers can measure various parameters of each cell, including size, shape, granularity, and the presence of specific proteins or molecules tagged with fluorescent markers. This information is then processed to create a multi-dimensional profile of the cell population, providing valuable insights into cell composition, health, and function. Major factors that drive growth of the flow cytometry market include technological advancements in the flow cytometry and high adoption of flow cytometry techniques in various research and diagnostic applications.
Technological advancements in flow cytometry have emerged as a major driver in the flow cytometry market, revolutionizing the capabilities and applications of this powerful analytical technique. Flow cytometry, which allows for the rapid analysis of thousands of individual cells or particles in a heterogeneous sample, has benefited greatly from ongoing innovations in recent years. Technological advancements in fluorescence imaging and image-based analysis have revolutionized the way researchers and clinicians analyze cells and particles in fluid samples.
Fluorescence imaging, a technique that allows the visualization of cells and particles tagged with fluorescent markers, has greatly enhanced the precision and sensitivity of flow cytometry. This technology enables the simultaneous measurement of multiple parameters within individual cells, providing detailed insights into cell structure and function. For instance, in January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study was conducted in collaboration with the European Molecular Biology Laboratory. The study evaluated new BD innovation in flow cytometry that adds fluorescence imaging and image-based analysis to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Thus, the technological advancement in the flow cytometry technology is expected to drive the growth of the market.
In addition, the high adoption of flow cytometry techniques has emerged as a major driving force in the growth of the flow cytometry market, owing to its widespread utilization in diverse research and diagnostic applications. Flow cytometry, a powerful analytical tool, has gained immense popularity in the scientific community due to its ability to simultaneously analyze multiple properties of individual cells or particles at a rapid pace. In research, it has become indispensable for studying cell biology, immunology, and cancer research, allowing scientists to analyze cell populations, sort specific cell types, and assess various cellular characteristics such as size, shape, and molecular markers. Flow cytometry has also revolutionized the field of clinical diagnostics. In the realm of clinical medicine, it plays a pivotal role in the diagnosis and monitoring of various diseases, including hematological malignancies, immunodeficiency disorders, and HIV. The ability to analyze and quantify specific biomarkers on individual cells has made flow cytometry an invaluable tool for clinical laboratories. For instance, according to a 2022 report by the National Library of Medicine, flow cytometry analysis plays a critical role in the diagnosis of leukemias and other hematolymphoid malignancies. Flow cytometry can quickly identify the abnormal cell population, characterize its phenotype, give lineage classification, make the diagnosis, or narrow down the differential list. Thus, the high adoption of flow cytometry technique in various research and diagnostic applications is expected to drive the growth of the market.
However, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Moreover, preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms and replaceable components. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others.
On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. As per application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others.
The diagnostic applications segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global flow cytometry market are Agilent Technologies, Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.
Technological advancements in flow cytometry have emerged as a major driver in the flow cytometry market, revolutionizing the capabilities and applications of this powerful analytical technique. Flow cytometry, which allows for the rapid analysis of thousands of individual cells or particles in a heterogeneous sample, has benefited greatly from ongoing innovations in recent years. Technological advancements in fluorescence imaging and image-based analysis have revolutionized the way researchers and clinicians analyze cells and particles in fluid samples.
Fluorescence imaging, a technique that allows the visualization of cells and particles tagged with fluorescent markers, has greatly enhanced the precision and sensitivity of flow cytometry. This technology enables the simultaneous measurement of multiple parameters within individual cells, providing detailed insights into cell structure and function. For instance, in January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study was conducted in collaboration with the European Molecular Biology Laboratory. The study evaluated new BD innovation in flow cytometry that adds fluorescence imaging and image-based analysis to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Thus, the technological advancement in the flow cytometry technology is expected to drive the growth of the market.
In addition, the high adoption of flow cytometry techniques has emerged as a major driving force in the growth of the flow cytometry market, owing to its widespread utilization in diverse research and diagnostic applications. Flow cytometry, a powerful analytical tool, has gained immense popularity in the scientific community due to its ability to simultaneously analyze multiple properties of individual cells or particles at a rapid pace. In research, it has become indispensable for studying cell biology, immunology, and cancer research, allowing scientists to analyze cell populations, sort specific cell types, and assess various cellular characteristics such as size, shape, and molecular markers. Flow cytometry has also revolutionized the field of clinical diagnostics. In the realm of clinical medicine, it plays a pivotal role in the diagnosis and monitoring of various diseases, including hematological malignancies, immunodeficiency disorders, and HIV. The ability to analyze and quantify specific biomarkers on individual cells has made flow cytometry an invaluable tool for clinical laboratories. For instance, according to a 2022 report by the National Library of Medicine, flow cytometry analysis plays a critical role in the diagnosis of leukemias and other hematolymphoid malignancies. Flow cytometry can quickly identify the abnormal cell population, characterize its phenotype, give lineage classification, make the diagnosis, or narrow down the differential list. Thus, the high adoption of flow cytometry technique in various research and diagnostic applications is expected to drive the growth of the market.
However, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Moreover, preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms and replaceable components. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others.
On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. As per application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others.
The diagnostic applications segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global flow cytometry market are Agilent Technologies, Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow cytometry market analysis from 2022 to 2032 to identify the prevailing flow cytometry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the flow cytometry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global flow cytometry market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Component
- Instruments
- Type
- Platform
- Replaceable component
- Reagents and consumables
- Type
- Antibodies
- Dyes
- Beads
- Others
- Software
- Services
By Technology
- Cell based flow cytometry
- Bead based flow cytometry
By Application
- Academic and clinical applications
- Type
- Cell Cycle Analysis and Cell Proliferation
- Apoptosis
- Cell Sorting
- Transfect Ion and Cell Viability
- Others
- Diagnostic applications
- Type
- Organ Transplantation
- Hematological Malignancies
- HIV
- Solid Tumors and Cancer
- Others
By End User
- Hospitals
- Medical schools and clinical testing labs
- Commercial organizations
- Academic institutions
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH.
- Sartorius AG
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Danaher Corporation
- Cytek Biosciences
- BioMerieux SA
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: FLOW CYTOMETRY MARKET, BY COMPONENT
CHAPTER 5: FLOW CYTOMETRY MARKET, BY TECHNOLOGY
CHAPTER 6: FLOW CYTOMETRY MARKET, BY APPLICATION
CHAPTER 7: FLOW CYTOMETRY MARKET, BY END USER
CHAPTER 8: FLOW CYTOMETRY MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, the flow cytometry market was valued at $4.7 billion in 2021, and is estimated to reach $10.4 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.Flow cytometry is a biophysical, laser-based analytical technology, which is used to measure and analyze cells in a fluid system. Cells under analysis are labelled using fluorescent techniques and then excited using laser to emit light at different wavelengths to analyze characteristics of cells or particles. During the process, a sample of cells or particles is suspended in fluid and injected into a flow cytometer machine. Approximately 10,000 cells can be analyzed and processed by a computer in less than one minute.
The flow cytometry market share is growing steadily in recent years, owing to rapid technological advancements, increase in investments in research & development and its extensive application in research & diagnostics. Further, wide scope of applications in different fields, increasing demands for advanced medical facilities, and increase in incidences of diseases such as cancer and HIV majorly supplement growth of in the global flow cytometry market. Alternatively, high costs of flow cytometry procedures and lack of awareness & trained personnel are key factors are expected to hamper the flow cytometry market size.
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The situation of COVID-19 has varied outcome when related to vaccinations. There is an emerging gap in the economic recovery between high-income and low and middle income countries. After the pandemic severely disrupted global trade, the world is witnessing a robust rebound, which is helping with the recovery in the year 2021. Trade contributes to speeding up economic recovery from the pandemic by providing sustained foreign demand for exports and ensuring the availability of imported intermediate products and services. Amidst the initial outbreak of COVID-19, the outlook for the flow cytometry industry was positively impacted by the COVID-19 pandemic. The surge in application of flow cytometry techniques in research activities and clinical trials have increased the demand for flow cytometry products. For instance, Cytek Biosciences Inc. helped researchers and clinicians in the world to study impact of the COVID-19 virus on human immune systems in March 2020. Flow cytometry showed that COVID-19 patients reduced B-cell and T-cell frequencies compared to recovered donors and healthy donors. Moreover, according to the data by the National Institute of health (NIH), the flow cytometry analysis at the time of first evaluation after admission revealed significant differences among patients with moderate diseases with a severe phenotype and critical phenotype in U.S.
Overall, the COVID-19 pandemic had a positive impact on the flow cytometry industry, owing to the advantages, the flow cytometry technology has showed in research of COVID-19 like the ability to conduct immunophenotyping that allows the identification of SARS-CoV-2-specific immune responses. Moreover, the manufacturers also supplied more products, owing to increased demand from research institutions.
The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms, replaceable components, and accessories. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others. On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others. The diagnostic application segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of component, the flow cytometry market analysis showed that the instruments segment accounted for the highest market share in 2021, owing to development of novel instrument designs, demand for highly efficient replaceable components, applications in treatment of newer diseases, and increase in research & developments in flow cytometry techniques. Reagents & consumables are expected to emerge as the leading segment as they are essentials in flow cytometry analysis. In addition, combination of imaging capabilities and instruments further boost instrument performance and make it more accessible to emerging economies.
On the basis of technology, the bead-based flow cytometry segment is expected to exhibit the fastest growth, registering a CAGR of 8.6% from 2022 to 2031, owing to flow cytometry market trends like wide scale use of technology in research field, lesser time consumption, and simultaneous analysis of multiple samples. However, the cell-based flow cytometry segment is the highest revenue generating segment, owing to its wide scale application in the diagnosis of various diseases such as cancer and HIV, biomedical research, and its increasing use in monitoring the progress of drug treatment.
On the basis of application, academic & clinical applications segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to increase in research of academic & clinical applications academic & clinical applications of flow cytometry. However, the diagnostic applications segment is expected to exhibit a prominent growth rate, owing to rise in use of technology in diagnostic applications.
On the basis of end user, the commercial organizations segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to heavy investments in R&D activities, advancements in cell- and bead-based technologies, growing patient population, and increasing demand for flow cytometry in drug discovery process. This segment is expected to exhibit a prominent growth rate of 9.0%, owing to increase in novel clinical applications and immunoassay processes, and diversified applications of flow cytometry in diseases diagnosis.
North America accounted for the highest revenue in the flow cytometry market in 2021. According to the flow cytometry market forecast, the market growth in the North America is supplemented by rapid technological advancements, increase in investments in research & development activities, rise in patent pool, and rise in the number of applications. However, Asia-Pacific is expected to emerge as the leading region, by registering a CAGR of 9.6% during the forecast period. This is mainly attributed to major international companies outsourcing their research processes to contract research organizations (CROs) located in Asia-Pacific. Moreover, impending need for sophisticated healthcare facilities and rise in incidences of chronic diseases such as HIV and cancer is expected to boost the market growth.
KEY FINDINGS OF STUDY
By component, the reagents & consumables segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 10.5% from 2022 to 2031.By technology, the bead-based flow cytometry segment is projected to grow at a CAGR of 8.6% during the forecast period.
By application, diagnostic applications segment is projected to grow at a CAGR of 8.5% during the forecast period.
By end user, the commercial organizations segment is projected to grow at a CAGR of 9.0% during the forecast period.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.6% during the forecast period.
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH.
- Sartorius AG
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Danaher Corporation
- Cytek Biosciences
- BioMerieux SA
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
